Burr: Accelerated Approval Reforms Left Out Because FDA Didn’t Request Them

By John Wilkerson / May 19, 2022 at 4:16 PM
Sen. Richard Burr (R-NC) said he didn’t include drug accelerated approval reforms in the draft FDA user fee bill he wrote with Senate health committee Chair Patty Murray (D-WA) because he likes the accelerated approval program and FDA did not ask for changes to it. However, the agency did request that Congress reform the program, both in the president’s budget request and at congressional hearings, and the House version of the user fee bill gives FDA more power over accelerated...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.